{"schema_version":"1","generated_at":"2026-11-13T11:27:05.803Z","data_as_of":null,"url":"https://www.findmykol.com/kol/angela-jain","json_url":"https://www.findmykol.com/kol/angela-jain/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"angela-jain","name":"Angela Jain","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Fox Chase Cancer Center","institution_url":"https://www.findmykol.com/institution/fox-chase-cancer-center","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1760624290","openalex":"A5044669637"},"summary":"Angela Jain is an Oncology physician affiliated with Fox Chase Cancer Center. OpenAlex indexes 38 publications with 1,720 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":38,"cited_by_count":1720,"h_index":9,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02050009","title":"Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","phase":"PHASE1","status":"WITHDRAWN","role":"Overall official","sponsor":"Fox Chase Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT02050009","trial_url":"https://www.findmykol.com/trial/NCT02050009"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":19,"shown":3,"withheld":16,"rows":[{"payer":"Jazz Pharmaceuticals","program_year":2025,"amount_usd":122728.12,"payment_count":19,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760624290"},{"payer":"Genmab","program_year":2025,"amount_usd":45869.8,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760624290"},{"payer":"GSK","program_year":2025,"amount_usd":174.8,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760624290"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1760624290","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":65.7,"classes_total":4,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":35.9,"drugs":[{"name":"Anastrozole","share_pct":64.8},{"name":"Letrozole","share_pct":23.2},{"name":"Exemestane","share_pct":11.9}],"max_beneficiaries":57},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":20.4,"drugs":[{"name":"Ibrance","share_pct":40.9},{"name":"Verzenio","share_pct":30.1},{"name":"Lenvima","share_pct":21},{"name":"Mekinist","share_pct":8}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":17.6,"classes_total":5,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":4.8,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":12},{"class":"Atypical Antipsychotic","setting":"prescribed","share_pct":4.1,"drugs":[{"name":"Olanzapine","share_pct":100}],"max_beneficiaries":25}]},{"area":"Metabolism & gastrointestinal","share_pct":9.5,"classes_total":3,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":5.6,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":34},{"class":"Corticosteroid","setting":"prescribed","share_pct":2.5,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":12.3,"facility_pct":87.7},"source":"medicare"},"publications":{"total":38,"shown":5,"withheld":33,"matched_by":"OpenAlex author record","recent":[{"title":"Role of Sentinel Node Surgery in Identifying Candidates for Adjuvant CDK4/6 Inhibitors: Implications of Choosing Wisely and ASCO Omission Criteria","year":2026,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-026-20131-3","status":"verified"},{"title":"Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study","year":2026,"journal":"JCO Precision Oncology","source_url":"https://doi.org/10.1200/po-25-00985","status":"verified"},{"title":"ASO Visual Abstract: Role of Sentinel Node Surgery in Identifying Candidates for Adjuvant CDK4/6 Inhibitors: Implications of Choosing Wisely and ASCO Omission Criteria","year":2026,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-026-20169-3","status":"verified"},{"title":"Exposure–Response Relationship of Dostarlimab in Primary Advanced/Recurrent Endometrial Cancer: Results From Interim Analysis 2 of Part 1 of the RUBY Trial","year":2026,"journal":"Clinical Pharmacology in Drug Development","source_url":"https://doi.org/10.1002/cpdd.70087","status":"verified"},{"title":"Second Primary Ovarian Malignancies after Radiation Therapy for Cervical Cancer and Considerations Regarding Risk-Reducing Salpingo-Oophorectomy: A Surveillance, Epidemiology, and End Results (SEER) Database Study","year":2026,"journal":"Journal of Gynecologic Surgery","source_url":"https://doi.org/10.1177/10424067261497806","status":"verified"}],"source":"works"},"contact":{"address_1":"333 COTTMAN AVE","city":"Philadelphia","state":"PA","zip":"191112434","phone":"215-728-6900","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1760624290","source":"identity"},"similar":[{"name":"Elizabeth Plimack","slug":"elizabeth-plimack","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/elizabeth-plimack","json_url":"https://www.findmykol.com/kol/elizabeth-plimack/profile.json"},{"name":"Robert Uzzo","slug":"robert-uzzo","institution":"Fox Chase Cancer Center","specialty":"Urology","url":"https://www.findmykol.com/kol/robert-uzzo","json_url":"https://www.findmykol.com/kol/robert-uzzo/profile.json"},{"name":"Alexander Kutikov","slug":"alexander-kutikov","institution":"Fox Chase Cancer Center","specialty":"Urology","url":"https://www.findmykol.com/kol/alexander-kutikov","json_url":"https://www.findmykol.com/kol/alexander-kutikov/profile.json"},{"name":"Martin Edelman","slug":"martin-edelman","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/martin-edelman","json_url":"https://www.findmykol.com/kol/martin-edelman/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":16,"publications":33}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-09-06","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}